The Little Green Pharma Ltd (ASX: LGP) share price is well in the green today, currently up 3.7% at 70 cents after soaring 7% higher this morning.
Below we take a look at the ASX cannabis share’s quarterly results that look to be driving investor interest.
What did the quarterly update reveal?
Little Green Pharma’s share price is soaring after the company reported “strong revenue growth” and a record month of sales for September.
Unaudited revenue came in at $3.18 million while the company reported an all-time monthly high of $1.39 million in sales for September.
As at 30 September, Little Green Pharma had a cash position of $29.1 million. It reported that, “Cash receipts lagged sales as debtors missed the cut-off for the month, with over $900,000 being received in the first few days of the current quarter.”
Growth and acquisitions
The Little Green Pharma share price may also be getting a boost from the strong growth in its Australian market. The company reported 4,580 new patients, a 39% quarter-on-quarter increase. And 110 new prescribers represented an increase of 46% from new prescribers coming on board during the previous quarter.
During the quarter, the company also completed its $6 million acquisition of “the properties underlying its cultivation and manufacturing facilities in Western Australia, as well as the two adjoining properties”.
Little Green Pharma said it was continuing to focus on European commercial sales. In line with that, the company has started integration of its Danish facility.
Atop its cannabis offering, the company also is progressing with its psychedelics business. In September, the Western Australian State Health department revised Little Green Pharma’s Schedule 9 licence “to permit the supply of psilocybin”.
Little Green Pharma share price snapshot
Over the past 12 months, the Little Green Pharma share price has rocketed 105.8%. That compares to a gain of 24% posted by the All Ordinaries Index (ASX: XAO) over that same time.
Little Green Pharma’s shares have been trading relatively flat over the past month.
The post Little Green Pharma (ASX:LGP) share price leaps 7% on revenue growth appeared first on The Motley Fool Australia.
Should you invest $1,000 in Little Green Pharma right now?
Before you consider Little Green Pharma, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Little Green Pharma wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
More reading
- How did ASX healthcare shares perform in the FY22 first quarter?
- Little Green Pharma (ASX:LGP) share price lifts as bosses reflect on a big year
The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3bfCCd2
Leave a Reply